Comparison of MMSE (Mini-Mental State Examination) and MoCA (Montreal Cognitive Assessment) in Cognitive Assessment in Geriatric Oncology

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02558907

Acronym

MoCA

Enrollment

Registered

2015-09-24

Start date

2015-09-30

Completion date

2017-03-31

Last updated

2017-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Geriatrics

Keywords

geriatrics, cancer, MMS test, MoCA test, cognitive evaluation

Brief summary

Compare neurocognitive testing MMSE (Mini-Mental State Examination) and MoCA (Montreal Cognitive Assessment) to candidates aged patients with 1st line treatment of their cancer will be received an examination oncogériatric

Interventions

OTHERcognitive evaluation by MMS (Mini-Mental State Examination) and MoCA (Montreal Cognitive Assessment) tests

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

71 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patient old over 70 years * Patient with cancer (solid tumor or hematological) for which a 1st line treatment is planned * Patient candidate an oncogeriatric assessment * Patient agreeing to participate in the study * French language * Lack of subsequent neurological sequelae with cognitive impact stroke, dementia or progressive psychiatric disorder * Patient having a life expectancy ≥ 6 months

Exclusion criteria

* Primitive cancer of the central nervous system or brain metastasis * Patients unable to meet the cognitive tests * Refusal to participate * Realization of a MMSE or MoCA test in the last 6 months

Design outcomes

Primary

Measure	Time frame
proportion of patients with cognitive disorders identified by the MoCA or the MMSE prior to treatment	before their first treatment for the cancer, at inclusion

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026